BIOMAT Database Logo BIOMAT Database Logo

[Haemolytic disease of the newborn (fetus) (author's transl)]. 1976

K Fischer, and A Poschmann

Haemolytic disease of the newborn is mostly caused by Rh antibody anti-D (Rh erythroblastosis) and antibodies of the ABO system anti-A and anti-B (ABO erythroblastosis). Because of possible fetal death in utero prenatal diagnosis and treatment of Rh erythroblastosis is necessary. Prophylactic administration of anti-Rh-gammaglobulin prevents the induction of Rh antibodies. In contrast to Rh erythroblastosis prenatal diagnosis and treatment of ABO erythroblastosis is not necessary. Postnatally, however, hyperbilirubinemia due to ABO erythroblastosis should be treated to avoid Kernicterus. Our results with diagnosis and treatment of haemolytic diseases of the newborn are presented and related to the literature. Furthermore, immunofluorescence studies are reported, which could possibly explain the differences between Rh and ABO erythroblastosis.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D001805 Blood Transfusion, Intrauterine In utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis (ERYTHROBLASTOSIS, FETAL). Fetal Transfusion,Intrauterine Transfusion,Blood Transfusions, Intrauterine,Fetal Transfusions,Intrauterine Blood Transfusion,Intrauterine Blood Transfusions,Intrauterine Transfusions,Transfusion, Fetal,Transfusion, Intrauterine,Transfusion, Intrauterine Blood,Transfusions, Fetal,Transfusions, Intrauterine,Transfusions, Intrauterine Blood
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group

Related Publications

K Fischer, and A Poschmann
Haemolytic disease of the fetus and newborn.
August 2015, Vox sanguinis,
K Fischer, and A Poschmann
[Haemolytic disease of the newborn due to anti-Duffy (author's transl)].
December 1974, Deutsche medizinische Wochenschrift (1946),
K Fischer, and A Poschmann
RhD haemolytic disease of the fetus and the newborn.
March 2000, Blood reviews,
K Fischer, and A Poschmann
[Spleen rupture in an infant with haemolytic disease of the newborn (author's transl)].
January 1977, Sangre,
K Fischer, and A Poschmann
Prevention of rhesus haemolytic disease of the fetus and newborn.
March 2009, Lancet (London, England),
K Fischer, and A Poschmann
Anti-U and haemolytic disease of the fetus and newborn.
December 1998, British journal of obstetrics and gynaecology,
K Fischer, and A Poschmann
Use of darbepoetin alfa in haemolytic disease of the fetus and newborn.
December 2023, The Lancet. Haematology,
K Fischer, and A Poschmann
[Correlation between severity of haemolytic disease of the newborn and impairment of placental maturation (author's transl)].
October 1973, Geburtshilfe und Frauenheilkunde,
K Fischer, and A Poschmann
[A new report of haemolytic disease of the newborn due to IgG anti-M (author's transl)].
January 1980, Sangre,
K Fischer, and A Poschmann
Deaths from Rh haemolytic disease of the fetus and newborn, 1977-87.
July 1989, Journal of the Royal College of Physicians of London,
Copied contents to your clipboard!